miR-21 might target the MAPK signaling pathway, PI3K/AKT signaling pathway, and mTOR signaling pathway (Table 2) (151) to increase the risk of macrosomia and metabolic diseases in the future. The gene discussed is AKT1; the disease is Large for gestational age.